Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Lilly, Sanford-Burnham partner to develop new immunological therapies Eli Lilly and Company and Sanford-Burnham Medical Research Institute have entered into a collaboration agreement to discover and develop new immunological therapies. Contract Research & Services > Contract Research > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Bayer and Janssen extend clinical investigation of cancer drug Xarelto
By PBR Staff Writer
Bayer HealthCare and Janssen Pharmaceuticals have started the Callisto Clinical Research Program to explore the potential benefits of the oral Factor Xa inhibitor Xarelto (rivaroxaban) to prevent and treat pulmonary embolism and deep vein thrombosis in patients with various types of cancer.
News
Celldex begins Phase I/II trial of varlilumab-sunitinib combination to treat CC-RCC
By PBR Staff Writer
US-based Celldex Therapeutics has started an open-label, Phase I/II safety and tolerability trial evaluating the investigational combination of varlilumab and sunitinib (Sutent) in patients with metastatic clear cell renal cell carcinoma (CC-RCC).
News

Contract Research

Boehringer, Michigan of to study mechanisms of diabetic nephropathy in Pima Indians
Boehringer Ingelheim and the University of Michigan announce today that they have entered into a research collaboration focused on the discovery of new medicines for patients with diabetic nephropathy.
News
Amgen launches program to further advance basic biology research
Amgen has announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology, as well as deepen relationships with academic institutions.
News

Contract Services

Galenica to commercialize Roche’s Mircera in US and Puerto Rico
By PBR Staff Writer
Serbian pharmaceutical firm Galenica has entered into an exclusive license agreement for the commercialization of Swiss drug-maker Roche’s prescription medicine Mircera (methoxy polyethylene glycol-epoetin beta) in the US and Puerto Rico.
News
Akron Biotech enters into strategic partnership with Cognate BioServices
Cognate BioServices and Akron Biotechnology are pleased to announce a strategic partnership that brings two industry leaders together to provide a more complete package of services to their clients.
News